Open AccessImaging of Hematological Patients in the Era of COVID-19
Author(s) -
Yael Eshet,
Abraham Avigdor,
Meirav Kedmi,
Noam Tau
Publication year - 2022
Publication title -
acta haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.574
H-Index - 56
eISSN - 1421-9662
pISSN - 0001-5792
DOI - 10.1159/000522323
Subject(s) - medicine , asymptomatic , covid-19 , pandemic , disease , pneumonia , intensive care medicine , population , hematological malignancy , differential diagnosis , malignancy , pathology , infectious disease (medical specialty) , environmental health
The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), resulted in changes in management and imaging routines for patients with hematological malignancies. Treating physicians had to familiarize themselves with a new disease, with distinct imaging manifestations, sometimes overlapping with other infections prevalent in this patient population. In some aspects, infected hematological patients might exhibit a different disease course, and routine imaging in asymptomatic hematological patients may result in unexpected COVID-19 findings, implying covert infection, that should be further explored. Furthermore, some complications of hematological diseases and treatments may present with findings similar to COVID-19 manifestations, and treating physicians must consider both possibilities in the differential diagnosis. In this review, we aim to present the influence the COVID-19 pandemic had on hematological malignancies imaging.